Connect with us

National Consumer News

Recall alert: Torrent Pharmaceuticals expands Losartan tablets recall

FDA.gov

By: Natalie Dreier, Cox Media Group National Content Desk

Torrent Pharmaceuticals Limited has once again expanded its recall of Losartan potassium tablets and Losartan potassium/hydrochlorothiazide tablets, the Food and Drug Administration announced Thursday.

The company has added an additional 36 lots of Losartan potassium tablets and 68 lots of Losartan potassium/hydrochlorothiazide tablets.

The recall is due once again to an impurity called N-Methylnitrosobutric acid or NMBA. 

The recalled lots have more NMBA than what is acceptable for daily intake set by the FDA.

Consumers with medical questions connected to the recall are being instructed to call Torrent Pharmaceuticals at 1-800-912-9561 or email Medinfo.Torrent@apcerls.com.

For more information, including the complete list of batch numbers included with the recall’s expansion, click here.

Recall alert: Macleods Pharmaceuticals pulls Losartan from shelves

Uncategorized

Recall alert: Honda Ridgelines recalled, could catch fire after using car wash

Uncategorized

Office Depot and tech support firm to pay $35 million after investigation by Jesse Jones

Jesse’s Story of the Day

Recall alert: Watermelon juice recalled, could contain plastic

Uncategorized